Micha Drukker

Biography

 Micha Drukker performed his PhD thesis at The Hebrew University in Israel, and post doctoral studies at Stanford University Medical School, where he gained the knowledge and developed techniques with which tissue progenitor cells can be isolated very efficiently from mixed cultures of differentiating human pluripotent stem cells. Since 2012 he has been heading the junior research group “Human Pluripotent Stem Cell Lineage Choice” and the core facility “Human Induced Pluripotent Stem Cells” at the Institute of Stem Cell Research at Helmholtz Zentrum München in Germany. Dr. Drukker’s current research encompass the mechanisms that regulate differentiation and misbehavior in disease of tissue-regenerating progenitor cells from pluripotent stem cells, including beta cells that are the cornerstone for therapy of type 1 diabetes.

Research Interest

 Oncology